Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
120M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
9.41M
-
Shares change
-
+127K
-
Total reported value, excl. options
-
$115M
-
Value change
-
-$1.38M
-
Put/Call ratio
-
0.78
-
Number of buys
-
31
-
Number of sells
-
-15
-
Price
-
$12.26
Significant Holders of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) as of Q2 2021
69 filings reported holding IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value as of Q2 2021.
IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.41M shares
of 120M outstanding shares and own 7.82% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (1.79M shares), FMR LLC (1.19M shares), BlackRock Inc. (1.13M shares), RTW INVESTMENTS, LP (921K shares), VANGUARD GROUP INC (712K shares), Artal Group S.A. (700K shares), Parkman Healthcare Partners LLC (414K shares), STATE STREET CORP (351K shares), Ghost Tree Capital, LLC (265K shares), and GEODE CAPITAL MANAGEMENT, LLC (259K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.